0.7928
price down icon0.90%   -0.0072
after-market Handel nachbörslich: .81 0.0172 +2.17%
loading
Schlusskurs vom Vortag:
$0.80
Offen:
$0.79
24-Stunden-Volumen:
110.65K
Relative Volume:
0.49
Marktkapitalisierung:
$62.80M
Einnahmen:
$8.23M
Nettoeinkommen (Verlust:
$-32.49M
KGV:
-1.4958
EPS:
-0.53
Netto-Cashflow:
$-19.91M
1W Leistung:
-4.48%
1M Leistung:
+4.18%
6M Leistung:
-16.55%
1J Leistung:
-36.06%
1-Tages-Spanne:
Value
$0.79
$0.8194
1-Wochen-Bereich:
Value
$0.77
$0.84
52-Wochen-Spanne:
Value
$0.7001
$1.65

Clearside Biomedical Inc Stock (CLSD) Company Profile

Name
Firmenname
Clearside Biomedical Inc
Name
Telefon
678-270-3631
Name
Adresse
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Name
Mitarbeiter
32
Name
Twitter
@clearsidebio
Name
Nächster Verdiensttermin
2025-03-18
Name
Neueste SEC-Einreichungen
Name
CLSD's Discussions on Twitter

Vergleichen Sie CLSD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CLSD
Clearside Biomedical Inc
0.7928 62.80M 8.23M -32.49M -19.91M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-21 Eingeleitet Chardan Capital Markets Buy
2024-06-25 Eingeleitet Oppenheimer Outperform
2021-12-15 Fortgesetzt Wedbush Outperform
2021-07-29 Eingeleitet H.C. Wainwright Buy
2020-05-13 Eingeleitet ROTH Capital Buy
2019-08-09 Herabstufung Needham Buy → Hold
2018-11-05 Herabstufung Cowen Outperform → Market Perform
2018-11-05 Herabstufung JP Morgan Overweight → Underweight
2018-11-05 Herabstufung Stifel Buy → Hold
2018-03-06 Bestätigt Needham Buy
2017-05-25 Eingeleitet JMP Securities Mkt Outperform
2017-02-24 Eingeleitet JP Morgan Overweight
2016-11-10 Bestätigt Needham Buy
2016-10-24 Bestätigt Stifel Buy
Alle ansehen

Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten

pulisher
Jun 18, 2025

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

Clearside Biomedical Announces Multiple Presentations to be Feat - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting | CLSD Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Clearside Biomedical Showcases Suprachoroidal Injection Platform for Retinal Diseases at CTS Meeting - Nasdaq

Jun 17, 2025
pulisher
Jun 16, 2025

Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types - GlobeNewswire Inc.

Jun 16, 2025
pulisher
Jun 10, 2025

Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jun 10, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Has $157,000 Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World

Jun 04, 2025
pulisher
May 30, 2025

Clearside Biomedical Approves Share Increase at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know - MSN

May 30, 2025
pulisher
May 28, 2025

Clearside Biomedical (CLSD) Gets a Buy from H.C. Wainwright - The Globe and Mail

May 28, 2025
pulisher
May 27, 2025

Clearside Biomedical’s SWOT analysis: eye disease stock faces funding hurdles amid promising pipeline - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Clearside Biomedical target cut to $5 by H.C. Wainwright - Investing.com

May 27, 2025
pulisher
May 25, 2025

HC Wainwright Lowers Clearside Biomedical (NASDAQ:CLSD) Price Target to $5.00 - Defense World

May 25, 2025
pulisher
May 23, 2025

Clearside Biomedical (CLSD) Price Target Lowered by Analyst | CL - GuruFocus

May 23, 2025
pulisher
May 23, 2025

H.C. Wainwright Adjusts Price Target for Clearside Biomedical (C - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Clearside Biomedical (CLSD) Price Target Lowered by Analyst | CLSD Stock News - GuruFocus

May 23, 2025
pulisher
May 21, 2025

Clearside Biomedical to Participate in a Fireside Chat at the St - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum | CLSD Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Clearside Biomedical Reveals Next-Gen Eye Therapy Platform at Exclusive Stifel Conference - Stock Titan

May 21, 2025
pulisher
May 19, 2025

Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Price Target at $5.00 - Defense World

May 19, 2025
pulisher
May 18, 2025

JMP Securities Reiterates “Market Outperform” Rating for Clearside Biomedical (NASDAQ:CLSD) - Defense World

May 18, 2025
pulisher
May 17, 2025

Clearside Biomedical (NASDAQ:CLSD) Raised to Hold at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

Needham & Company LLC Lowers Clearside Biomedical (NASDAQ:CLSD) Price Target to $3.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

JMP maintains $5 target on Clearside Biomedical stock By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Clearside Biomedical (CLSD) Reiterates Market Outperform Rating - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Clearside Biomedical Reports Q1 2025 Financial Progress - TipRanks

May 16, 2025
pulisher
May 15, 2025

Clearside Biomedical (CLSD) Target Price Lowered by Needham | CL - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 15, 2025
pulisher
May 15, 2025

Stifel maintains Buy on Clearside Biomedical, target at $8 By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Stifel maintains Buy on Clearside Biomedical, target at $8 - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings: EPS Matches Es - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Clearside (CLSD) Reports Strong Q1 Revenue Boost | CLSD Stock Ne - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings: EPS Matches Estimates at -$0.11, Revenue Surges to $2.3 Million, Exceeding Expectations - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside Biomedical Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

CLEARSIDE BIOMEDICAL Earnings Results: $CLSD Reports Quarterly Earnings - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Clearside (CLSD) Reports Strong Q1 Revenue Boost | CLSD Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside's Wet AMD Drug Advances to Phase 3: FDA Green Light Could Transform Eye Disease Treatment - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Clearside Biomedical (NASDAQ:CLSD) Cut to “Sell” at StockNews.com - Defense World

May 12, 2025
pulisher
May 10, 2025

Investor Network: Clearside Biomedical, Inc. to Host Earnings Call - ACCESS Newswire

May 10, 2025

Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Clearside Biomedical Inc-Aktie (CLSD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Chong Ngai Hang Victor
Chief Medical Officer
Nov 01 '24
Buy
1.00
36,500
36,500
100,000
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):